Drug profile · INN
ulipristal
ESMYA
ulipristal (ESMYA) is a progesterone receptor modulator.
EMA: withdrawn Genito-urinary system and sex hormones (G03) G03XB02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ulipristal
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
ulipristal (ESMYA) is a progesterone receptor modulator.
Key facts
INN ulipristal
Brand ESMYA
Mechanism Progesterone receptor modulator
Target Progesterone receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03XB02
Mechanism of action
Progesterone receptor modulator
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is ulipristal?
ulipristal (ESMYA) is a progesterone receptor modulator.
What is the brand name for ulipristal?
ESMYA is a marketed brand name for ulipristal. Check FDA Drugs@FDA for the current US label holder and prescribing information.